These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25565621)

  • 1. Medical innovation then and now: perspectives of innovators responsible for transformative drugs.
    Xu S; Kesselheim AS
    J Law Med Ethics; 2014; 42(4):564-75. PubMed ID: 25565621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation.
    Kesselheim AS; Xu S; Avorn J
    PLoS One; 2014; 9(2):e88664. PubMed ID: 24533133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origins of medical innovation: the case of coronary artery stents.
    Xu S; Avorn J; Kesselheim AS
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):743-9. PubMed ID: 23093563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sanford Lorraine Cross Award for medical innovation: Advancing a rigorous and repeatable method for recognizing translational research leaders who today are bringing emerging transformative innovations to patients.
    Horowitz M; Simkins J; Pearce DA
    J Clin Transl Res; 2020 Jan; 5(2):80-90. PubMed ID: 32377583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of public-sector research in the discovery of drugs and vaccines.
    Stevens AJ; Jensen JJ; Wyller K; Kilgore PC; Chatterjee S; Rohrbaugh ML
    N Engl J Med; 2011 Feb; 364(6):535-41. PubMed ID: 21306239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consideration on Academia Environments for Creating Medical Innovation].
    Iida K; Ishida T; Nishimura N
    Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology transfer from biomedical research to clinical practice: measuring innovation performance.
    Balas EA; Elkin PL
    Eval Health Prof; 2013 Dec; 36(4):505-17. PubMed ID: 24142938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs.
    Kesselheim AS; Tan YT; Avorn J
    Health Aff (Millwood); 2015 Feb; 34(2):286-93. PubMed ID: 25646109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of regulatory science on global public health.
    Patel M; Miller MA
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S5-9. PubMed ID: 22871603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual property rights, standards and data exchange in systems biology: Reflections from the IP Expert Meeting at the University of Luxembourg, 8-9 October 2015, ERASysAPP - ERA-Net for Systems Biology Applications.
    van Zimmeren E; Rutz B; Minssen T
    Biotechnol J; 2016 Dec; 11(12):1477-1480. PubMed ID: 27966844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the respective roles of the public and private sectors in pharmaceutical innovation?
    Sampat BN; Lichtenberg FR
    Health Aff (Millwood); 2011 Feb; 30(2):332-9. PubMed ID: 21289355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol as a transformative drug in anesthesia: insights from key early investigators.
    Bateman BT; Kesselheim AS
    Drug Discov Today; 2015 Aug; 20(8):1012-7. PubMed ID: 25936833
    [No Abstract]   [Full Text] [Related]  

  • 15. Scientific Prediction and Prophetic Patenting in Drug Discovery.
    Curry SH; Schneiderman AM
    Recent Pat CNS Drug Discov; 2015; 10(1):34-44. PubMed ID: 26088613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical entrepreneurism: the current opportunity in America.
    Lexa FJ
    J Am Coll Radiol; 2004 Oct; 1(10):762-8. PubMed ID: 17411697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.